Host Julia Cartwright investigates why GLP-1 drugs have become a game-changer for women over 40 struggling with perimenopausal weight gain. Each episode examines the science behind hormonal metabolism shifts, clinical trial results across reproductive stages, and critical safety concerns including bone density loss and muscle depletion. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.